chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Productive cough, Pyrexia, Rhinorrhoea, Throat irritation
Clinical narrative: Hoarse voice; Mucus from out of the chest; Fatigue; 100.4 F; Cough; Tickle in the back of the throat; Sore arm; "runny nose"; Systemic body pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSPHONIA (Hoarse voice), THROAT IRRITATION (Tickle in the back of the throat), PRODUCTIVE COUGH (Mucus from out of the chest), PAIN IN EXTREMITY (Sore arm) and RHINORRHOEA ("runny nose") in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), RHINORRHOEA ("runny nose") and MYALGIA (Systemic body pain). On 13-Jan-2021, the patient experienced THROAT IRRITATION (Tickle in the back of the throat) and COUGH (Cough). On 14-Jan-2021, the patient experienced DYSPHONIA (Hoarse voice), PRODUCTIVE COUGH (Mucus from out of the chest), FATIGUE (Fatigue) and PYREXIA (100.4 F). At the time of the report, DYSPHONIA (Hoarse voice), THROAT IRRITATION (Tickle in the back of the throat), PRODUCTIVE COUGH (Mucus from out of the chest), PAIN IN EXTREMITY (Sore arm), RHINORRHOEA ("runny nose"), COUGH (Cough), MYALGIA (Systemic body pain), FATIGUE (Fatigue) and PYREXIA (100.4 F) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication were not reported by the reporter. Treatment details were not reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jan-2021: New events updated
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Hypokinesia, Pain in extremity
Clinical narrative: Pain in the left arm; unable to lift/move her left arm above 15 degrees; arm is very sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the left arm), HYPOKINESIA (unable to lift/move her left arm above 15 degrees) and PAIN IN EXTREMITY (arm is very sore) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L209) for an unknown indication.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain in the left arm), HYPOKINESIA (unable to lift/move her left arm above 15 degrees) and PAIN IN EXTREMITY (arm is very sore). At the time of the report, PAIN IN EXTREMITY (Pain in the left arm), HYPOKINESIA (unable to lift/move her left arm above 15 degrees) and PAIN IN EXTREMITY (arm is very sore) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pain, Vaccination site erythema, Vaccination site pain
Clinical narrative: injection site itchy; rounf red circle at the injection site(2 inch diameter); Injection site getting sore again; Sore arm at injection site; Headache; Some fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm at injection site), HEADACHE (Headache), FATIGUE (Some fatigue), VACCINATION SITE PRURITUS (injection site itchy) and VACCINATION SITE ERYTHEMA (rounf red circle at the injection site(2 inch diameter)) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore arm at injection site), HEADACHE (Headache) and FATIGUE (Some fatigue). On 12-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE ERYTHEMA (rounf red circle at the injection site(2 inch diameter)) and INJECTION SITE PAIN (Injection site getting sore again). On 10-Jan-2021, VACCINATION SITE PAIN (Sore arm at injection site), HEADACHE (Headache) and FATIGUE (Some fatigue) outcome was unknown. At the time of the report, VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE ERYTHEMA (rounf red circle at the injection site(2 inch diameter)) and INJECTION SITE PAIN (Injection site getting sore again) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: injection site itchy; rounf red circle at the injection site(2 inch diameter); Injection site getting sore again; Sore arm at injection site; Headache; Some fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm at injection site), HEADACHE (Headache), FATIGUE (Some fatigue), VACCINATION SITE PRURITUS (injection site itchy) and VACCINATION SITE ERYTHEMA (rounf red circle at the injection site(2 inch diameter)) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore arm at injection site), HEADACHE (Headache) and FATIGUE (Some fatigue). On 12-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE ERYTHEMA (rounf red circle at the injection site(2 inch diameter)) and INJECTION SITE PAIN (Injection site getting sore again). On 10-Jan-2021, VACCINATION SITE PAIN (Sore arm at injection site), HEADACHE (Headache) and FATIGUE (Some fatigue) outcome was unknown. At the time of the report, VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE ERYTHEMA (rounf red circle at the injection site(2 inch diameter)) and INJECTION SITE PAIN (Injection site getting sore again) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling, Vaccination site pruritus
Clinical narrative: Injection site itching; Injection site redness; Big red mark around the injection site; Swollen; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Big red mark around the injection site), INJECTION SITE SWELLING (Swollen), INJECTION SITE ERYTHEMA (Injection site redness) and VACCINATION SITE PRURITUS (Injection site itching) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 300042460) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Big red mark around the injection site) and INJECTION SITE SWELLING (Swollen). On 14-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Injection site redness). On 15-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site itching). On 09-Jan-2021, INJECTION SITE ERYTHEMA (Big red mark around the injection site) and INJECTION SITE SWELLING (Swollen) had resolved. At the time of the report, INJECTION SITE ERYTHEMA (Injection site redness) and VACCINATION SITE PRURITUS (Injection site itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications not reported by the reporter. Treatment details not reported by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Big are like hives; Itchy at injection site; big red area below injection site; Area at injection site slightly raised; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Big are like hives), INJECTION SITE PRURITUS (Itchy at injection site), INJECTION SITE ERYTHEMA (big red area below injection site) and INJECTION SITE SWELLING (Area at injection site slightly raised) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy, Insomnia and Herpes NOS. Concomitant products included VALACYCLOVIR [VALACICLOVIR] for Herpes NOS, TRAZODONE for Insomnia.   On 06-Jan-2021 at 11:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Jan-2021 at 8:00 AM, the patient experienced URTICARIA (Big are like hives) and INJECTION SITE SWELLING (Area at injection site slightly raised). 14-Jan-2021 at 8:00 AM, the patient experienced INJECTION SITE PRURITUS (Itchy at injection site) and INJECTION SITE ERYTHEMA (big red area below injection site). On 17-Jan-2021, INJECTION SITE PRURITUS (Itchy at injection site) and INJECTION SITE ERYTHEMA (big red area below injection site) had resolved. At the time of the report, URTICARIA (Big are like hives) and INJECTION SITE SWELLING (Area at injection site slightly raised) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment of the events included, diphenhydramine   This case was linked to MOD-2021-086626 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Follow up information was received on 22 Apr 2021 included, Race, ethnic group, height, weight of the patient.Current conditions and allergies were updated.Concomitant medications were reported.Event outcome was updated from recovering to resolved on 17 Jan 2021.second dose information added with the events. On 03-Jun-2021: No specific follow-up information recorded.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness and tenderness after shot; A spontaneous report was received from a male patient of unspecified age, who received Moderna's COVID-19 vaccine and experienced soreness and tenderness after shot/vaccination site tenderness.   The patient's medical history was not provided. No relevant concomitant medications were reported.    The patient had received high dose flu shot on left arm on an unspecified day in DEC-2020 (reported as 17 days ago)  On 14/Jan/2021, prior to the onset of events, the patient received their first of two planned doses of mRNA-1273 (lot number unknown) via unknown route in right arm for prophylaxis of COVID-19 infection.  In Jan/2021, after first dose of vaccine, the patient experienced soreness and tenderness after shot. No treatment information was provided.   Action taken with mRNA-1273 in response to the event was not reported..  The outcome of the event, soreness and tenderness after shot was resolving at the time of this report.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Fatigue, Injection site pain, SARS-CoV-2 test positive
Clinical narrative: arm tenderness; very sore by the injection site; fatigue; Chills; tested positive for COVID; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for COVID), TENDERNESS (arm tenderness), INJECTION SITE PAIN (very sore by the injection site), FATIGUE (fatigue) and CHILLS (Chills) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism. Concomitant products included ETHINYLESTRADIOL, NORETHISTERONE ACETATE (JUNEL) for an unknown indication, LEVOTHYROXINE.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for COVID). On an unknown date, the patient experienced TENDERNESS (arm tenderness), INJECTION SITE PAIN (very sore by the injection site), FATIGUE (fatigue) and CHILLS (Chills). On 15-Jan-2021, TENDERNESS (arm tenderness), INJECTION SITE PAIN (very sore by the injection site), FATIGUE (fatigue) and CHILLS (Chills) had resolved. At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, COVID-19: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    Treatment for the symptoms included Tylenol.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: arm tenderness; very sore by the injection site; fatigue; Chills; tested positive for COVID; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for COVID), TENDERNESS (arm tenderness), INJECTION SITE PAIN (very sore by the injection site), FATIGUE (fatigue) and CHILLS (Chills) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism. Concomitant products included ETHINYLESTRADIOL, NORETHISTERONE ACETATE (JUNEL) for an unknown indication, LEVOTHYROXINE.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for COVID). On an unknown date, the patient experienced TENDERNESS (arm tenderness), INJECTION SITE PAIN (very sore by the injection site), FATIGUE (fatigue) and CHILLS (Chills). On 15-Jan-2021, TENDERNESS (arm tenderness), INJECTION SITE PAIN (very sore by the injection site), FATIGUE (fatigue) and CHILLS (Chills) had resolved. At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, COVID-19: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    Treatment for the symptoms included Tylenol.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Headache
Clinical narrative: Lingering metallic taste; Sharp headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEADACHE (Sharp headache) and DYSGEUSIA (Lingering metallic taste) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced HEADACHE (Sharp headache) and DYSGEUSIA (Lingering metallic taste). On 30-Dec-2020, HEADACHE (Sharp headache) and DYSGEUSIA (Lingering metallic taste) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment medications were unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Culture urine, Diarrhoea, Dysuria, Haematuria
Clinical narrative: couldn't urinate; blood in my urine; diarrhea; her arm sore all to her wrist; injection site is warm to touch; injection site very itchy; Her whole body ached; area was red around the injection site, 4-5 inches long and 2-3 inches; got a fever of 99.4 F.; Her whole body ached; very sore injection site; This spontaneous case was reported by a consumer and describes the occurrence of DYSURIA (couldn't urinate), HAEMATURIA (blood in my urine), DIARRHOEA (diarrhea), PAIN IN EXTREMITY (her arm sore all to her wrist) and VACCINATION SITE WARMTH (injection site is warm to touch) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced VACCINATION SITE PAIN (very sore injection site). On 17-Jan-2021, the patient experienced PAIN IN EXTREMITY (her arm sore all to her wrist), VACCINATION SITE WARMTH (injection site is warm to touch), VACCINATION SITE PRURITUS (injection site very itchy), the first episode of MYALGIA (Her whole body ached), VACCINATION SITE ERYTHEMA (area was red around the injection site, 4-5 inches long and 2-3 inches), PYREXIA (got a fever of 99.4 F.) and the second episode of MYALGIA (Her whole body ached). On 18-Jan-2021, the patient experienced DYSURIA (couldn't urinate), HAEMATURIA (blood in my urine) and DIARRHOEA (diarrhea). On 12-Jan-2021, VACCINATION SITE PAIN (very sore injection site) had resolved. At the time of the report, DYSURIA (couldn't urinate), HAEMATURIA (blood in my urine) and DIARRHOEA (diarrhea) outcome was unknown and PAIN IN EXTREMITY (her arm sore all to her wrist), VACCINATION SITE WARMTH (injection site is warm to touch), VACCINATION SITE PRURITUS (injection site very itchy), VACCINATION SITE ERYTHEMA (area was red around the injection site, 4-5 inches long and 2-3 inches), PYREXIA (got a fever of 99.4 F.) and the last episode of MYALGIA (Her whole body ached) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Jan-2021, Body temperature: 99.4 (High) Units: F. On 17-Jan-2021, Culture urine: blood in urine (abnormal) clinician mentioned I had some blood in my urine but that it was due to my taking the blood thinner.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient reported taking Blood thinner concomitantly. She took 6 Benadryl throughout the day and 2 Tylenol when she got the fever. The medication did not help. Patient clinician mentioned she had some blood in her urine but that it was due to her taking the blood thinner. She had diarrhea and took Imodium. She was prescribed the antibiotic nitrofurantoin for 7 days. She was able to pass about one ounce of urine.   This case was linked to MOD-2021-036938 (Patient Link).
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site warmth
Clinical narrative: couldn't urinate; blood in my urine; diarrhea; her arm sore all to her wrist; injection site is warm to touch; injection site very itchy; Her whole body ached; area was red around the injection site, 4-5 inches long and 2-3 inches; got a fever of 99.4 F.; Her whole body ached; very sore injection site; This spontaneous case was reported by a consumer and describes the occurrence of DYSURIA (couldn't urinate), HAEMATURIA (blood in my urine), DIARRHOEA (diarrhea), PAIN IN EXTREMITY (her arm sore all to her wrist) and VACCINATION SITE WARMTH (injection site is warm to touch) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced VACCINATION SITE PAIN (very sore injection site). On 17-Jan-2021, the patient experienced PAIN IN EXTREMITY (her arm sore all to her wrist), VACCINATION SITE WARMTH (injection site is warm to touch), VACCINATION SITE PRURITUS (injection site very itchy), the first episode of MYALGIA (Her whole body ached), VACCINATION SITE ERYTHEMA (area was red around the injection site, 4-5 inches long and 2-3 inches), PYREXIA (got a fever of 99.4 F.) and the second episode of MYALGIA (Her whole body ached). On 18-Jan-2021, the patient experienced DYSURIA (couldn't urinate), HAEMATURIA (blood in my urine) and DIARRHOEA (diarrhea). On 12-Jan-2021, VACCINATION SITE PAIN (very sore injection site) had resolved. At the time of the report, DYSURIA (couldn't urinate), HAEMATURIA (blood in my urine) and DIARRHOEA (diarrhea) outcome was unknown and PAIN IN EXTREMITY (her arm sore all to her wrist), VACCINATION SITE WARMTH (injection site is warm to touch), VACCINATION SITE PRURITUS (injection site very itchy), VACCINATION SITE ERYTHEMA (area was red around the injection site, 4-5 inches long and 2-3 inches), PYREXIA (got a fever of 99.4 F.) and the last episode of MYALGIA (Her whole body ached) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Jan-2021, Body temperature: 99.4 (High) Units: F. On 17-Jan-2021, Culture urine: blood in urine (abnormal) clinician mentioned I had some blood in my urine but that it was due to my taking the blood thinner.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient reported taking Blood thinner concomitantly. She took 6 Benadryl throughout the day and 2 Tylenol when she got the fever. The medication did not help. Patient clinician mentioned she had some blood in her urine but that it was due to her taking the blood thinner. She had diarrhea and took Imodium. She was prescribed the antibiotic nitrofurantoin for 7 days. She was able to pass about one ounce of urine.   This case was linked to MOD-2021-036938 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Myalgia, Vaccination site pain
Clinical narrative: injection site was swollen up, big, red; chills; diarrhea; joint and muscle pain; Joint pain; arm was sore; A spontaneous report was received from a consumer concerning a 40 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273)  first dose on 05-01-2021 in right arm (intramuscularly).  on 5-012021 injection site was swollen up became big and red.   on 7-01-2021 patient experienced the following events which are chills, diarrhea, joint and muscle pain..  The patient's had Covid-19 on june month as medical history. No relevant concomitant medications were reported.    On 18/Jan/2021, the patient experienced events pain at her injection site for 2 days, had congestion, headache, nausea, fever, body aches and no apetite.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: injection site was swollen up, big, red; chills; diarrhea; joint and muscle pain; Joint pain; arm was sore; A spontaneous report was received from a consumer concerning a 40 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273)  first dose on 05-01-2021 in right arm (intramuscularly).  on 5-012021 injection site was swollen up became big and red.   on 7-01-2021 patient experienced the following events which are chills, diarrhea, joint and muscle pain..  The patient's had Covid-19 on june month as medical history. No relevant concomitant medications were reported.    On 18/Jan/2021, the patient experienced events pain at her injection site for 2 days, had congestion, headache, nausea, fever, body aches and no apetite.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Nausea
Clinical narrative: nausea; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea) and ARTHRALGIA (joint pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced NAUSEA (nausea) and ARTHRALGIA (joint pain). At the time of the report, NAUSEA (nausea) and ARTHRALGIA (joint pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact; Sender's Comments: Very limited information regarding this events has been provided at this time.  Further information has been requested.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Limb discomfort, Lymphadenopathy, Peripheral swelling
Clinical narrative: throat started to swell; arm pain; lymph node swelling; left cheek was itchy; chills; fever; arm swelling; This spontaneous case was reported by a consumer and describes the occurrence of   in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA), MIRTAZAPINE, MONTELUKAST SODIUM (SINGULAIR), HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL + HIDROCLOROTIAZIDA), FEXOFENADINE HYDROCHLORIDE (ALLEGRA), OMEPRAZOLE, AMLODIPINE and ACETYLSALICYLIC ACID (ASPIRIN 1000).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.7 Degree F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling, Pruritus, Pyrexia
Clinical narrative: throat started to swell; arm pain; lymph node swelling; left cheek was itchy; chills; fever; arm swelling; This spontaneous case was reported by a consumer and describes the occurrence of   in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA), MIRTAZAPINE, MONTELUKAST SODIUM (SINGULAIR), HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL + HIDROCLOROTIAZIDA), FEXOFENADINE HYDROCHLORIDE (ALLEGRA), OMEPRAZOLE, AMLODIPINE and ACETYLSALICYLIC ACID (ASPIRIN 1000).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.7 Degree F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: Rash at injection site; Itchy at injection site; Warm at injection site; Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the injection site), VACCINATION SITE RASH (Rash at injection site), VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE WARMTH (Warm at injection site) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032H20A) for COVID-19 immunisation.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site). On 15-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash at injection site), VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE WARMTH (Warm at injection site). On 09-Jan-2021, VACCINATION SITE PAIN (Soreness at the injection site) had resolved. On 17-Jan-2021, VACCINATION SITE RASH (Rash at injection site), VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE WARMTH (Warm at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided  Cortisone cream was given as Treatment medication for Itchiness.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Follow up received on 02-Jul -2021: contain No New Information.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Dehydration, Fatigue, Myalgia
Clinical narrative: Fever; Weak; Muscle aches; Not eating; Had no water; Lost 4 pounds; Stayed in bed all day; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), ASTHENIA (Weak), MYALGIA (Muscle aches), DECREASED APPETITE (Not eating) and DEHYDRATION (Had no water) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PYREXIA (Fever), ASTHENIA (Weak), MYALGIA (Muscle aches), DECREASED APPETITE (Not eating), DEHYDRATION (Had no water), WEIGHT DECREASED (Lost 4 pounds) and FATIGUE (Stayed in bed all day). On 17-Jan-2021, MYALGIA (Muscle aches), DECREASED APPETITE (Not eating) and DEHYDRATION (Had no water) had resolved. At the time of the report, PYREXIA (Fever) had resolved, ASTHENIA (Weak) had not resolved and WEIGHT DECREASED (Lost 4 pounds) and FATIGUE (Stayed in bed all day) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Weight decreased
Clinical narrative: Fever; Weak; Muscle aches; Not eating; Had no water; Lost 4 pounds; Stayed in bed all day; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), ASTHENIA (Weak), MYALGIA (Muscle aches), DECREASED APPETITE (Not eating) and DEHYDRATION (Had no water) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PYREXIA (Fever), ASTHENIA (Weak), MYALGIA (Muscle aches), DECREASED APPETITE (Not eating), DEHYDRATION (Had no water), WEIGHT DECREASED (Lost 4 pounds) and FATIGUE (Stayed in bed all day). On 17-Jan-2021, MYALGIA (Muscle aches), DECREASED APPETITE (Not eating) and DEHYDRATION (Had no water) had resolved. At the time of the report, PYREXIA (Fever) had resolved, ASTHENIA (Weak) had not resolved and WEIGHT DECREASED (Lost 4 pounds) and FATIGUE (Stayed in bed all day) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Red spot, 8-10 centimeters, 14 centimeters wrapping around my arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red spot, 8-10 centimeters, 14 centimeters wrapping around my arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event history).    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red spot, 8-10 centimeters, 14 centimeters wrapping around my arm). At the time of the report, VACCINATION SITE ERYTHEMA (Red spot, 8-10 centimeters, 14 centimeters wrapping around my arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Injection site erythema, Injection site pain, Injection site swelling, Pruritus
Clinical narrative: a strip coming up raised an inch above and below the injection site; experiencing redness which is now 4x2in which looks like sunburn on his left arm; Itchy; Burning; Real Bright Red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (a strip coming up raised an inch above and below the injection site), INJECTION SITE ERYTHEMA (experiencing redness which is now 4x2in which looks like sunburn on his left arm), PRURITUS (Itchy), INJECTION SITE PAIN (Burning) and ERYTHEMA (Real Bright Red) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced INJECTION SITE SWELLING (a strip coming up raised an inch above and below the injection site), INJECTION SITE ERYTHEMA (experiencing redness which is now 4x2in which looks like sunburn on his left arm), PRURITUS (Itchy), INJECTION SITE PAIN (Burning) and ERYTHEMA (Real Bright Red). At the time of the report, INJECTION SITE SWELLING (a strip coming up raised an inch above and below the injection site), INJECTION SITE ERYTHEMA (experiencing redness which is now 4x2in which looks like sunburn on his left arm), PRURITUS (Itchy), INJECTION SITE PAIN (Burning) and ERYTHEMA (Real Bright Red) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Cold sweat, Nausea
Clinical narrative: Cold sweats; Nausea; High blood pressure; This spontaneous case was reported by an other health care professional and describes the occurrence of COLD SWEAT (Cold sweats), NAUSEA (Nausea) and BLOOD PRESSURE INCREASED (High blood pressure) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for an unknown indication.     The patient's past medical history included No adverse event.    On 11-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced COLD SWEAT (Cold sweats), NAUSEA (Nausea) and BLOOD PRESSURE INCREASED (High blood pressure). At the time of the report, COLD SWEAT (Cold sweats), NAUSEA (Nausea) and BLOOD PRESSURE INCREASED (High blood pressure) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant information provided. No treatment information provided.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Ultrasound abdomen
Clinical narrative: got vaccine while being pregnant; A spontaneous report was received from a health care professional who was a 35-year-old female patient who received Moderna's COVID-19 vaccine and she was 11 weeks pregnant.   Patient's medical history included congenital heart disease in 2014 and supraventricular tachycardia in 2018 and a surgery was done in 2018 and concomitant medicines reported as taken by the patient included prenatal vitamins, baby aspirin, metoprolol, Dexilant, Pepcid.        The pregnancy history of the patient included 3 prior pregnancy history with 2 live, full term birth on 11-FEB-2016 and 25-AUG-2017   and one spontaneous abortion on 22-SEP-2020.  On 14 JAN 2021, the patient received the first of two planned doses of mRNA-1273 intramuscularly in the left deltoid (non-dominant arm) for prophylaxis of COVID-19 infection. On 14 NOV 2020, the patient had a positive pregnancy test. The first day of the patient's last menstrual period was on 23 OCT 2020. The estimated date of conception was unknown, and the due date was estimated as 31 JUL 2021. The patient has prior history of use of alcohol and was allergic to Amoxicillan and levoquin  The laboratory investigations include ultrasound and genetic testing on 14-JAN-2021, the reports were unknown. Action taken with mRNA-1273 was not reported.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccination site pain
Clinical narrative: Contracted COVID; There was little pain the day after the arm; This spontaneous case was reported by a health care professional and describes the occurrence of COVID-19 (Contracted COVID) and VACCINATION SITE PAIN (There was little pain the day after the arm) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced COVID-19 (Contracted COVID) and VACCINATION SITE PAIN (There was little pain the day after the arm). At the time of the report, COVID-19 (Contracted COVID) and VACCINATION SITE PAIN (There was little pain the day after the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: No specific follow-up information recorded.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain around the injection site) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE PAIN (pain around the injection site). At the time of the report, VACCINATION SITE PAIN (pain around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chills, Cough
Clinical narrative: Fatigued; Cough; No sense of smell; Loss of taste; Covid test positive; Fever; Chills; Headache; body ache; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of COUGH (Cough), ANOSMIA (No sense of smell), AGEUSIA (Loss of taste), COVID-19 (Covid test positive) and PYREXIA (Fever) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jan-2021, the patient experienced COUGH (Cough), ANOSMIA (No sense of smell), AGEUSIA (Loss of taste), COVID-19 (Covid test positive), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (body ache). On 17-Jan-2021, the patient experienced FATIGUE (Fatigued). On 17-Jan-2021, COUGH (Cough), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (body ache) had resolved. At the time of the report, ANOSMIA (No sense of smell), AGEUSIA (Loss of taste), COVID-19 (Covid test positive) and FATIGUE (Fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication were not reported by the reporter. Treatment included Advair inhalation and cough pill.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Fatigued; Cough; No sense of smell; Loss of taste; Covid test positive; Fever; Chills; Headache; body ache; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of COUGH (Cough), ANOSMIA (No sense of smell), AGEUSIA (Loss of taste), COVID-19 (Covid test positive) and PYREXIA (Fever) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jan-2021, the patient experienced COUGH (Cough), ANOSMIA (No sense of smell), AGEUSIA (Loss of taste), COVID-19 (Covid test positive), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (body ache). On 17-Jan-2021, the patient experienced FATIGUE (Fatigued). On 17-Jan-2021, COUGH (Cough), PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (body ache) had resolved. At the time of the report, ANOSMIA (No sense of smell), AGEUSIA (Loss of taste), COVID-19 (Covid test positive) and FATIGUE (Fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication were not reported by the reporter. Treatment included Advair inhalation and cough pill.
Sex: F
Vaccine: COVID19
Symptoms: Anaesthesia oral, Dysphonia, Feeling hot, Headache, Heart rate
Clinical narrative: sore arm; heat feeling "warm throughout her body"; tachycardia shot up to 130 BPs for 20 mins; alter sensation in her tongue; her voice had mild hoarseness; period palpitations over the next 12 hours or so; looked pale; not feeling well; headache; This spontaneous case was reported by a physician and describes the occurrence of   in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concomitant products included PREDNISONE.    On 08-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, Heart rate: 130 bps 130 bps.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 08-Jan-2021, the patient experienced heat feeling "warm feeling through out her body" similar to IV contrast for an MRI. Tachycardia shot up to 130BPS for 20 minutes at the same time alter sensation in her tongue and her voice had "mild hoarseness" then the tachycardia came back to normal over the next hour. She had period palpitations over the next 12 hours or so. Headache started that evening on 08-Jan-2021 and she looked "pale". The patient was just not feeling well. On 09-Jan-2021, morning just had sore arm but overall the patient felt great. The patient was on tapering course of prednisone for IBU. Concomitant medications were not provided. Treatment information was not reported.